Camille Chakiba

1.6k total citations
35 papers, 798 citations indexed

About

Camille Chakiba is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Camille Chakiba has authored 35 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Camille Chakiba's work include Sarcoma Diagnosis and Treatment (7 papers), Frailty in Older Adults (6 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Camille Chakiba is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), Frailty in Older Adults (6 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Camille Chakiba collaborates with scholars based in France, Belgium and Italy. Camille Chakiba's co-authors include Pierre Soubeyran, Alain Ravaud, Marine Gross‐Goupil, Amandine Quivy, Charlotte Domblides, Amaury Daste, Anne Floquet, M. Rainfray, Simone Mathoulin‐Pélissier and Carine Bellera and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Camille Chakiba

31 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camille Chakiba France 15 370 316 167 125 113 35 798
Catherine Fortpied Belgium 16 405 1.1× 291 0.9× 162 1.0× 141 1.1× 96 0.8× 52 1.0k
Noam A. VanderWalde United States 16 269 0.7× 242 0.8× 149 0.9× 98 0.8× 103 0.9× 48 822
V. Servent France 12 610 1.6× 352 1.1× 300 1.8× 304 2.4× 224 2.0× 30 1.2k
Yukiyoshi Esaki Japan 20 569 1.5× 358 1.1× 59 0.4× 71 0.6× 142 1.3× 52 1.3k
Christophe Desauw France 8 305 0.8× 209 0.7× 212 1.3× 44 0.4× 143 1.3× 27 603
Aytuğ Üner Türkiye 15 400 1.1× 189 0.6× 31 0.2× 105 0.8× 144 1.3× 70 786
Isabelle Neyroud‐Caspar Switzerland 13 724 2.0× 256 0.8× 66 0.4× 631 5.0× 37 0.3× 19 1.2k
Jong Seok Lee South Korea 12 215 0.6× 146 0.5× 37 0.2× 56 0.4× 32 0.3× 18 478
Ian S. Dayes Canada 19 559 1.5× 1.1k 3.6× 32 0.2× 305 2.4× 63 0.6× 65 2.0k
Dylan J. Martini United States 17 729 2.0× 422 1.3× 41 0.2× 124 1.0× 95 0.8× 68 1.0k

Countries citing papers authored by Camille Chakiba

Since Specialization
Citations

This map shows the geographic impact of Camille Chakiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille Chakiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille Chakiba more than expected).

Fields of papers citing papers by Camille Chakiba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camille Chakiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille Chakiba. The network helps show where Camille Chakiba may publish in the future.

Co-authorship network of co-authors of Camille Chakiba

This figure shows the co-authorship network connecting the top 25 collaborators of Camille Chakiba. A scholar is included among the top collaborators of Camille Chakiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camille Chakiba. Camille Chakiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mathoulin‐Pélissier, Simone, H. Charitansky, Yann Godbert, et al.. (2023). Evaluating video-based consultations in routine clinical practice at a comprehensive cancer center. Acta Oncologica. 62(12). 1905–1912. 1 indexed citations
2.
Agostinetto, Elisa, Guilherme Nader Marta, Marianne Paesmans, et al.. (2022). ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast. Future Oncology. 18(22). 2383–2392. 15 indexed citations
4.
Toulmonde, Maud, Mehdi Brahmi, Antoine Giraud, et al.. (2020). LBA67 TRAMUNE, a phase Ib study combining trabectedin and durvalumab, results of the expansion cohort in patients with advanced pretreated soft tissue sarcomas. Annals of Oncology. 31. S1199–S1199. 5 indexed citations
6.
Croce, Sabrina, Tom Lesluyes, Carine Valle, et al.. (2019). The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas. Clinical Cancer Research. 26(4). 855–861. 15 indexed citations
7.
Chakiba, Camille, et al.. (2019). The prognostic value of G8 for functional decline. Journal of Geriatric Oncology. 10(6). 921–925. 17 indexed citations
8.
Orbach, Daniel, Véronique Mosseri, Daniel Pissaloux, et al.. (2018). Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience. Cancer Medicine. 7(4). 1384–1393. 19 indexed citations
9.
Béchade, Dominique, et al.. (2018). Toxicité hépatique des inhibiteurs des tyrosines kinases : mécanismes en cause et conséquences pratiques. Bulletin du Cancer. 105(3). 290–298. 7 indexed citations
11.
Daste, Amaury, Charlotte Domblides, Marine Gross‐Goupil, et al.. (2017). Immune checkpoint inhibitors and elderly people: A review. European Journal of Cancer. 82. 155–166. 139 indexed citations
12.
Daste, Amaury, Camille Chakiba, Charlotte Domblides, et al.. (2016). Targeted therapy and elderly people: A review. European Journal of Cancer. 69. 199–215. 28 indexed citations
13.
Chakiba, Camille, Thomas Grellety, Sophie Cousin, & Antoîne Italiano. (2016). Risks and benefits of phase 1 oncology trials in the era of personalized medicine. Annals of Oncology. 27. vi476–vi476. 1 indexed citations
14.
Soubeyran, Pierre, C. Terret, Carine Bellera, et al.. (2016). Role of geriatric intervention in the treatment of older patients with cancer: rationale and design of a phase III multicenter trial. BMC Cancer. 16(1). 932–932. 21 indexed citations
16.
Chakiba, Camille, L. Mignot, Nicolas Madranges, et al.. (2015). Efficacy and tolerance of everolimus in 123 consecutive advanced ER positive, HER2 negative breast cancer patients. A two center retrospective study. The Breast. 24(6). 718–722. 9 indexed citations
17.
Debled, Marc, Camille Chakiba, & Gaëtan MacGrogan. (2015). Utiliser une signature moléculaire pour la prise en charge d'une patiente atteinte d'un cancer du sein : la quête du Graal…. Bulletin du Cancer. 102(6). S106–S110. 1 indexed citations
18.
Chakiba, Camille, F. Cornélis, E. Descat, et al.. (2015). Dynamic contrast enhanced MRI-derived parameters are potential biomarkers of therapeutic response in bladder carcinoma. European Journal of Radiology. 84(6). 1023–1028. 24 indexed citations
20.
Hoppe, Stéphanie, M. Rainfray, Marianne Fonck, et al.. (2013). Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy. Journal of Clinical Oncology. 31(31). 3877–3882. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026